Viewing Study NCT05361668


Ignite Creation Date: 2025-12-24 @ 5:40 PM
Ignite Modification Date: 2026-01-25 @ 4:29 AM
Study NCT ID: NCT05361668
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-31
First Post: 2022-04-27
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome
Sponsor: Crinetics Pharmaceuticals Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Carcinoid Syndrome View
None Carcinoid View
None Carcinoid Tumor View
None Carcinoid Tumor of Ileum View
None Carcinoid Tumor of Cecum View
None Carcinoid Syndrome Diarrhea View
None Carcinoid Intestine Tumor View
None Carcinoid Tumor of Liver View
None Carcinoid Tumor of Pancreas View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Neuroendocrine tumor View
None Paltusotine View
None CRN00808 View
None Carcinoid syndrome View
None Lanreotide View
None Octreotide View
None Somatostatin agonist View